Cancer TherapyConfirmed
China Approved the World’s First CAR-T Therapy for a Solid Tumor
Satri-cel crossed a historic regulatory line in stomach cancer, but the approval is limited to China and the first patients have not yet been dosed.
Why now
CAR-T has moved beyond blood-cancer approvals and into its first approved solid-tumor indication.
- Overclaim risk
- high
- Primary source
- Wire
- Published
- Jun 24, 2026
Read brief ->